GLENDA COLE: Open Payments
NPI 1538312715 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 12 payments from 10 companies in 2025. Trend: 2023 $1,434 · 2024 $1,929 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $61 |
| ABBVIE INC. | 2 | $38 |
| Philips North America LLC | 1 | $32 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Insmed, Inc. | 1 | $28 |
| Baxter Healthcare | 1 | $25 |
| Verona Pharma, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $15 |
Products named: INGREZZA, UBRELVY, Vest Therapy Und, XYWAV, Arikayce, Hillrom - Vest System Model 105 Home Care, Ohtuvayre, Sunosi.
Industry payments across AL — which companies pay providers there.
